Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Radius Heal (RDUS_OLD)

NASDAQ
Currency in USD
Disclaimer
10.08
0.00(0.00%)
Closed
RDUS_OLD Scorecard
Fair Value
Unlock Value
Day's Range
10.0610.18
52 wk Range
4.9723.00
Prev. Close
10.1
Open
10.1
Day's Range
10.06-10.18
52 wk Range
4.97-23
Volume
0
Average Volume (3m)
1,593,994
1-Year Change
0%
Shares Outstanding
47,600,500
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about RDUS_OLD?
Vote to see community's results!
or

Radius Heal Company Profile

Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. Its commercial product includes TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It also develops abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a transdermal system that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone-receptor-positive breast cancer; and RAD011, which is in Phase II clinical trials for the treatment of hyperphagia related to Prader-Willi syndrome. Radius Health, Inc. has a partnership with EffRx Pharmaceuticals. Radius Health, Inc. was formerly known as MPM Acquisition Corp. and changed its name to Radius Health, Inc. in May 2011. The company was incorporated in 2003 and is based in Boston, Massachusetts.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.